麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, May 14 2024

Full Issue

Despite Coverage Gains, Costs May Mask Biden's Health Care Efforts

A closer look at the numbers helps to explain the shift in political discourse from coverage to affordability. Also in the news: pressure to reduce drug prices, removing insurance perks for seniors, Medicaid unwinding, and more.

President Biden has come closer than any of his Democratic predecessors to reaching the party's long-standing goal of universal health coverage, but unaffordable care costs may overshadow the achievement. (Owens, 5/14)

Bernie Sanders urged Denmark to force its most valuable company, Novo Nordisk A/S, to lower its drug prices, in a letter submitted by the US senator to one of the Nordic country鈥檚 largest newspapers. Sanders, who chairs the Senate鈥檚 Health, Education, Labor and Pensions Committee, called on Danes to pressure Novo to 鈥渟ignificantly reduce the outrageously high prices for Ozempic and Wegovy in the US and other parts of the world,鈥 according to the letter, published by the Politiken newspaper on Monday. (Wienberg, 5/13)

Last year, looking to capitalize on a booming Medicare Advantage business, health insurer Aetna offered new perks for seniors. It would reimburse the purchase of hiking boots and national parks fees, for instance, it told clients. Now, Aetna is rolling back its promises. New instructions from federal regulators said insurers couldn鈥檛 reimburse for such items, the company said in memos issued to insurance brokers in recent weeks. (Merrilees, 5/13)

麻豆女优 Health News: Medicaid 鈥楿nwinding鈥 Decried As Biased Against Disabled People

Jacqueline Saa has a genetic condition that leaves her unable to stand and walk on her own or hold a job. Every weekday for four years, Saa, 43, has relied on a home health aide to help her cook, bathe and dress, go to the doctor, pick up medications, and accomplish other daily tasks. She received coverage through Florida鈥檚 Medicaid program until it abruptly stopped at the end of March, she said. (Chang, 5/14)

Rhode Island violated the civil rights of hundreds of children with mental health or developmental disabilities by routinely and unnecessarily segregating them at Bradley Hospital, an acute-care psychiatric hospital, federal prosecutors said Monday. Zachary Cunha, U.S. Attorney for the District of Rhode Island, said the multi-year investigation found that ... the state left them hospitalized at Bradley for months and in some cases for more than a year. (LeBlanc, 5/14)

In other news 鈥

The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk substance be approved, industry experts said. The current classification as a Schedule I substance has limited research into cannabis due to restricted access to cannabis products, regulatory hurdles and funding limitations. (Roy, 5/14)

In a matter of months, the Food and Drug Administration is expected to decide whether the drug commonly known as ecstasy can be used as a treatment for post-traumatic stress disorder. An approval by the agency would represent an enormous milestone for the movement to bring psychedelics into the mainstream of mental health care. An FDA rejection of MDMA, the abbreviation of the drug's chemical name, would deal a major setback to the effort. (Stone, 5/13)

Also 鈥

The U.S. Supreme Court on Monday denied an appeal from California corrections officials who sought immunity from lawsuits claiming they acted with deliberate indifference when they caused a deadly COVID-19 outbreak at one of the world鈥檚 most famous prisons four years ago. The justices turned down the appeal without comment or dissent. (Weber, 5/14)

Roughly 2,300 people in the U.S. died due to extreme heat in 2023. That risk is likely not going away soon, as scientists say climate change is causing more intense and frequent heat waves. To address that, the U.S. Centers for Disease Control and Prevention has released new tools to help people plan for higher temperatures across the country. (Thorp, 5/13)

On a bright June day in 2018, one of the nation鈥檚 top regulators waved groceries in the air, quizzing the secretary of agriculture on which agency is charged with monitoring different types of food. Scott Gottlieb, the commissioner of the Food and Drug Administration at the time, grinned widely as he held liquid egg whites and a carton of eggs. The former is under the U.S. Department of Agriculture鈥檚 food safety purview. The eggs, under the FDA鈥檚. The mood was jovial, winkingly acknowledging the complexity, and at times absurdity, in the way the government regulates food. (Zhang, Lawrence and Florko, 5/14)

A higher proportion of people who trekked through at least one country with endemic malaria on their way to three southern US border cities arrived with cases of the mosquito-borne illness鈥攏early a third of them with severe disease鈥攊n 2023 than in 2022, finds a聽study published in Morbidity and Mortality Weekly Report. Researchers from the Centers for Disease Control and Prevention (CDC) and local health departments conducted enhanced imported malaria case investigations from January to December 2023. (Van Beusekom, 5/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优